Abstract:Background: Most randomized controlled trials with a time-to-event outcome are designed assuming proportional hazards (PH) of the treatment effect. The sample size calculation is based on a logrank test. However, non-proportional hazards are increasingly common. At analysis, the estimated hazards ratio with a confidence interval is usually presented. The estimate is often obtained from a Cox PH model with treatment as a covariate. If non-proportional hazards are present, the logrank and equivalent Cox tests may lose power. To safeguard power, we previously suggested a 'joint test' combining the Cox test with a test of non-proportional hazards. Unfortunately, a larger sample size is needed to preserve power under PH. Here, we describe a novel test that unites the Cox test with a permutation test based on restricted mean survival time. Methods: We propose a combined hypothesis test based on a permutation test of the difference in restricted mean survival time across time. The test involves the minimum of the Cox and permutation test P-values. We approximate its null distribution and correct it for correlation between the two P-values. Using extensive simulations, we assess the type 1 error and power of the combined test under several scenarios and compare with other tests. We investigate powering a trial using the combined test. Results: The type 1 error of the combined test is close to nominal. Power under proportional hazards is slightly lower than for the Cox test. Enhanced power is available when the treatment difference shows an 'early effect', an initial separation of survival curves which diminishes over time. The power is reduced under a 'late effect', when little or no difference in survival curves is seen for an initial period and then a late separation occurs. We propose a method of powering a trial using the combined test. The 'insurance premium' offered by the combined test to safeguard power under non-PH represents about a single-digit percentage increase in sample size. Conclusions: The combined test increases trial power under an early treatment effect and protects power under other scenarios. Use of restricted mean survival time facilitates testing and displaying a generalized treatment effect.

More powerful logrank permutation tests for two-sample survival data

Partitioned Log-Rank Tests for the Overall Homogeneity of Hazard Rate Functions

A Class of Weighted Log-Rank Tests for Survival Data when the Event is Rare

Studentized Permutation Method for Comparing Two Restricted Mean Survival Times with Small Sample from Randomized Trials.

Optimality of testing procedures for survival data

Studentized Permutation Method for Comparing Restricted Mean Survival Times with Small Sample from Randomized Trials

Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipated

The weighted log-rank tests based on stratified clustered survival data: saddle-point p-values and confidence intervals

Survival analysis under non-proportional hazards: investigating non-inferiority or equivalence in time-to-event data

The Inverse Log-Rank Test: A Versatile Procedure for Late Separating Survival Curves

Inferring median survival differences in general factorial designs via permutation tests

A two-step approach for analyzing time to event data under non-proportional hazards

RMST‐based multiple contrast tests in general factorial designs

Testing the equality of two survival functions with right truncated data

RMST-based multiple contrast tests in general factorial designs

Two-sample survival tests based on control arm summary statistics

Which Test for Crossing Survival Curves? A User's Guideline.

Detecting rare and weak deviations of non-proportional hazard in survival analysis

Alternative Analysis Methods for Time to Event Endpoints under Non-proportional Hazards: A Comparative Analysis

Log-rank test with coarsened exact matching

Robust Tests for Treatment Effect in Survival Analysis under Covariate-Adaptive Randomization